Data / Drug companies / Bayer HealthCare LLC.
Bayer HealthCare LLC.: 78 products in the FDA NDC directory, labeler code 11523
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Bayer HealthCare LLC. (labeler code 11523) lists 78 products in the FDA National Drug Code Directory, covering 16 finished drugs by generic name. By type: 70 over the counter drugs, 8 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 3, 2026.
The request: Watch Bayer HealthCare LLC. (FDA labeler code 11523): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 11523
- Products in commercial distribution
- 78
- Packages
- 194
- Finished drugs by generic name
- 16
- Prescription products
- 0
- Over the counter products
- 70
- Flagged as original packager
- 69 of 69 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- July 14, 1975
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 42 | 53.8% |
| New drug applications (NDA) | 23 | 29.5% |
| Drugs for further processing | 8 | 10.3% |
| Generic drugs (ANDA) | 5 | 6.4% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 70 | 89.7% |
| Drugs for further processing | 8 | 10.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Loratadine | 18 | 125 |
| Oxymetazoline hydrochloride | 12 | 64 |
| Tolnaftate | 10 | 99 |
| Miconazole nitrate | 5 | 101 |
| Butenafine hydrochloride | 4 | 14 |
| Clotrimazole | 3 | 98 |
| Polyethylene glycol 3350 | 3 | 67 |
| Magnesium hydroxide | 2 | 41 |
| Loratadine and pseudoephedrine sulfate | 2 | 15 |
| Chlorpheniramine maleate, dextromethorphan hydrochloride | 1 | 2 |
| Topical starch | 1 | 1 |
| Loratadine pseudoephedrine sulfate | 1 | 1 |
| Acetaminophen and chlorpheniramine maleate | 1 | 3 |
| Chlorpheniramine maleate and dextromethorphan hydrobromide | 1 | 3 |
| Acetaminophen, guaifenesin | 1 | 6 |
| Docusate sodium | 1 | 79 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 10 | 12.8% |
| Cream | 9 | 11.5% |
| Aerosol, powder | 9 | 11.5% |
| Spray, metered | 7 | 9% |
| Tablet, chewable | 5 | 6.4% |
| Capsule | 4 | 5.1% |
| Powder | 4 | 5.1% |
| Kit | 4 | 5.1% |
| Spray | 4 | 5.1% |
| Tablet, film coated | 3 | 3.8% |
| Tablet, extended release | 3 | 3.8% |
| Powder, for solution | 3 | 3.8% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| MiraSOFT Stool Softener | 11523-8259 | Capsule, liquid filled | Over the counter monograph drugs | August 3, 2026 |
| Docusate sodium | 11523-8258 | Capsule | Drugs for further processing | December 15, 2025 |
| Loratidine | 11523-0166 | Capsule | Drugs for further processing | May 26, 2025 |
| Acetaminophen, guafenesin | 11523-0163 | Capsule | Drugs for further processing | May 12, 2025 |
| Coricidin HBP Maximum Strength Cold, Cough and Flu | 11523-0124 | Kit | Over the counter monograph drugs | May 12, 2025 |
| MiraFAST KIDS soft chews | 11523-8296 | Bar, chewable | Over the counter monograph drugs | February 17, 2025 |
| MiraFAST soft chews | 11523-0159 | Bar, chewable | Over the counter monograph drugs | February 17, 2025 |
| Claritin Allergy | 11523-0101 | Solution | New drug applications (NDA) | May 22, 2024 |
| Afrin No Drip Pump Mist Bundle Pack | 11523-0147 | Kit | Over the counter monograph drugs | April 19, 2024 |
| Tinactin Jock Itch | 11523-0138 | Aerosol, powder | Over the counter monograph drugs | March 1, 2024 |
| Tinactin Deodorant | 11523-0137 | Aerosol, powder | Over the counter monograph drugs | March 1, 2024 |
| Lotrimin Daily Prevent Deodorant | 11523-0136 | Aerosol, powder | Over the counter monograph drugs | March 1, 2024 |
| Lotrimin AF | 11523-0134 | Aerosol, powder | Over the counter monograph drugs | February 26, 2024 |
| Lotrimin Ultra Ringworm | 11523-0158 | Cream | New drug applications (NDA) | January 2, 2024 |
| Tinactin | 11523-0139 | Aerosol, powder | Over the counter monograph drugs | November 29, 2023 |
| Lotrimin AF Deodorant | 11523-0135 | Aerosol, powder | Over the counter monograph drugs | November 29, 2023 |
| Lotrimin AF Jock Itch | 11523-0133 | Aerosol, powder | Over the counter monograph drugs | November 29, 2023 |
| Lotrimin AF Jock Itch | 11523-0150 | Powder | Over the counter monograph drugs | November 6, 2023 |
| MiraLAX Orange Flavor | 11523-0122 | Powder, for solution | Generic drugs (ANDA) | September 15, 2023 |
| Claritin | 11523-0104 | Tablet, chewable | Generic drugs (ANDA) | February 5, 2023 |
| Claritin-D 24 Hour | 11523-0102 | Tablet, extended release | Generic drugs (ANDA) | December 12, 2022 |
| Children Afrin No Drip Extra Moisturizing Stuffy Nose Pump Mist Stuffy Nose Pump Mist | 11523-0090 | Spray, metered | Over the counter monograph drugs | July 6, 2022 |
| Children Afrin Extra Moisturizing Stuffy Nose Pump Mist Stuffy Nose Pump Mist | 11523-0091 | Spray, metered | Over the counter monograph drugs | July 3, 2022 |
| Coricidin HBP Maximum Strength Cold Flu And Chest Congestion | 11523-0094 | Capsule, gelatin coated | Over the counter monograph drugs | May 1, 2022 |
| Acetaminophen, guafenesin | 11523-0085 | Capsule | Drugs for further processing | March 9, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.